Amyloid-enhancing factor mediates amyloid formation on fibroblasts via a nidus/template mechanism

Arthritis and Rheumatism

Volumn 48, Issue 5, 2003, Pages 1430-1437

  Magy, Nadine ^a   Liepnieks, Juris J ^a   Benson, Merrill D ^a   Kluve Beckerman, Barbara ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID ENHANCING FACTOR; AMYLOID PRECURSOR PROTEIN; ANTISERUM; CONGO RED; SERUM AMYLOID A; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; AMYLOIDOSIS; ARTICLE; BETA SHEET; BINDING AFFINITY; BIREFRINGENCE; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CONFOCAL MICROSCOPY; FIBROBLAST; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRECIPITATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; WESTERN BLOTTING;

ANIMALS; APOLIPOPROTEINS; BIOPOLYMERS; CELLS, CULTURED; COLORING AGENTS; CONGO RED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLYCOPROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; MICE; MICROSCOPY, CONFOCAL; PROTEIN PRECURSORS; RECOMBINANT PROTEINS; SERUM AMYLOID A PROTEIN; SKIN; TEMPLATES, GENETIC;

EID: 0038666544     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10964     Document Type: Article

References (24)

1. Benson MD. Amyloidosis. In: Koopman WJ, editor. Arthritis and allied conditions, a textbook of rheumatology. 14th ed. Philadelphia: Lippincott; 2001. p. 1866-95.
2. Husby G, Marhaug G, Dowton B, Sletten K, Sipe JD. Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid 1994;1:119-37.
3. Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 1999;265:501-23.
4. Shirahama T, Cohen AS. Intralysosomal formation of amyloid fibrils. Am J Pathol 1975;81:101-16.
5. Takahashi M, Yokota T, Kawano H, Gondo T, Ishihara T, Uchino F. Ultrastructural evidence for intracellular formation of amyloid fibrils in macrophages. Virchows Arch 1989;415:411-9.
6. Chronopoulos S, Laird DW, Ali-Khan Z. Immunolocalization of serum amyloid A and AA amyloid in lysosomes in murine monocytoid cells: confocal and immunogold electron microscopic studies. J Pathol 1994;173:361-9.
7. 2-fibrils to AA-fibrils in amyloid fibrillogenesis: in vivo observations in murine spleen using anti-SAA and anti-AA antibodies. J Pathol 1994;173:127-34.
8. Miura K, Shirasawa H. Amyloid A (AA) fibril formation in renal tubules occurs intracytoplasmically, possibly at the site of membrane assembling structures. Amyloid 1994;1:107-13.
9. 2 in endosomes-lysosomes in activated macrophages and their degradation products. Amyloid 1996;4:40-8.
10. Kluve-Beckerman B, Liepnieks JJ, Wang L, Benson MD. A cell culture system for the study of amyloid pathogenesis: amyloid formation by peritoneal macrophages cultured with recombinant serum amyloid A. Am J Pathol 1999;155:123-33.
11. Kluve-Beckerman B, Manaloor JJ, Liepnieks JJ. A pulse-chase study tracking the conversion of macrophage-endocytosed serum amyloid A into extracellular amyloid. Arthritis Rheum 2002;46: 1905-13.
12. Sipe JD, McAdam KP, Uchino F. Biochemical evidence for the biphasic development of experimental amyloidosis. Lab Invest 1978;38:110-4.
13. Axelrad MA, Kisilevsky R, Willmer J, Chen SJ, Skinner M. Further characterization of amyloid-enhancing factor. Lab Invest 1992;47:139-46.
14. Kisilevsky R, Gruys E, Shirahama T. Does amyloid enhancing factor (AEF) exist? Is AEF a single biological entity? Amyloid 1995;2:128-34.
15. Ganowiak K, Hultman P, Engstrom U, Gustavsson A, Westermark P. Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice. Biochem Biophys Res Commun 1994;199:306-12.
16. Johan K, Westermark G, Engstrom U, Gustavsson A, Hultman P, Westermark P. Acceleration of amyloid protein A amyloidosis by amyloid-synthetic fibrils. Proc Natl Acad Sci U S A 1998;95: 2558-63.
17. Kisilevsky R, Lemieux L, Boudreau L, Dun-Sheng Y, Fraser P. New clothes for amyloid enhancing factor (AEF): silk as AEF. Amyloid 1999;6:98-106.
18. Kluve-Beckerman B, Yamada T, Hardwick J, Liepnieks JJ, Benson MD. Differential plasma clearance of murine acute-phase serum amyloid A proteins SAA1 and SAA2. Biochem J 1997;322: 663-9.
19. Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem 1962;10:355-64.
20. Schagger H, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987;166:368-79.
21. Kluve-Beckerman B, Song M, Benson MD, Liepnieks JJ. Recombinant murine serum amyloid A from baculovirus-infected insect cells: purification and characterization. Biochim Biophys Acta 1993;1182:303-10.
22. Kluve-Beckerman B, Manaloor J, Liepnieks JJ. Binding, trafficking, and accumulation of serum amyloid A in peritoneal macrophages. Scand J Immunol 2001;53:393-400.
23. Ancsin JB, Kisilevsky R. Characterization of high affinity binding between laminin and the acute-phase protein, serum amyloid A. J Biol Chem 1997;272:406-13.
24. Ancsin JB, Kisilevsky R. The heparin/heparan sulfate-binding site on apo-serum amyloid A: implications for the therapeutic intervention of amyloidosis. J Biol Chem 1999;274:7172-81.